Advanced search
Publication Cover
Substance Abuse Volume 36, 2015 - Issue 2: Expanding Treatment for Opioid Use Disorder: The Role of Pharmacotherapies
Journal homepage
764
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence

Heide JacksonDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USACorrespondence[email protected]
, MS,
Kara MandellDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
, PhD,
Kimberly JohnsonDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
, PhD,
Debanjana ChatterjeeDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
, PhD &
David J. VannessDepartment of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA
, PhD
Pages 226-231 | Published online: 06 May 2015

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Lien-Chung Wei & Hung-Yu Chan. (2021) Relationship between choice of opioid agonist therapy and distance from patients’ residences in Taiwan, 2012–2014. The American Journal of Drug and Alcohol Abuse 47:5, pages 590-598.
Read now
Ankit Shah, Margaret Duncan, Nipun Atreja, Kei Sing Tai & Mugdha Gore. (2018) Healthcare utilization and costs associated with treatment for opioid dependence. Journal of Medical Economics 21:4, pages 406-415.
Read now
John A. Carter, Ryan Dammerman & Michael Frost. (2017) Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder. Journal of Medical Economics 20:8, pages 893-901.
Read now

Articles from other publishers (25)

Stephen Orme, Gary A. Zarkin, Laura J. Dunlap, Laura B. Monico, Jan Gryczynski, Marc J. Fishman, Robert P. Schwartz, Kevin E. O'Grady & Shannon Gwin Mitchell. (2023) Health care use and cost of treatment for adolescents and young adults with opioid use disorder. Journal of Substance Use and Addiction Treatment 154, pages 209137.
Crossref
Rita Tabanelli, Simone Brogi & Vincenzo Calderone. (2023) Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?. International Journal of Molecular Sciences 24:13, pages 10888.
Crossref
Catherine Baxley, Brian Borsari, Jill V. Reavis, Jennifer K. Manuel, Ellen Herbst, William Becker, David Pennington, Steven L. Batki & Karen Seal. (2023) Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials. Addictive Behaviors 139, pages 107589.
Crossref
Richard Dodel, Christopher Kruse, Annette Conrads-Frank & Uwe Siebert. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 101 234 .
Magdalena Cerdá, Mohammad S Jalali, Ava D Hamilton, Catherine DiGennaro, Ayaz Hyder, Julian Santaella-Tenorio, Navdep Kaur, Christina Wang & Katherine M Keyes. (2021) A Systematic Review of Simulation Models to Track and Address the Opioid Crisis. Epidemiologic Reviews 43:1, pages 147-165.
Crossref
Elizabeth Beaulieu, Catherine DiGennaro, Erin Stringfellow, Ava Connolly, Ava Hamilton, Ayaz Hyder, Magdalena Cerdá, Katherine M. Keyes & Mohammad S. Jalali. (2021) Economic Evaluation in Opioid Modeling: Systematic Review. Value in Health 24:2, pages 158-173.
Crossref
Gary A. Zarkin, Stephen Orme, Laura J. Dunlap, Sharon M. Kelly, Shannon G. Mitchell, Kevin E. O’Grady & Robert P. Schwartz. (2020) Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail. Drug and Alcohol Dependence 217, pages 108292.
Crossref
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Carolina Barbosa, William N. Dowd & Gary Zarkin. (2020) Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies. Value in Health 23:8, pages 1096-1108.
Crossref
Barbara Andraka-Christou, Thuy Nguyen, David W. Bradford & Kosali Simon. (2020) Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorder. Journal of Substance Abuse Treatment 110, pages 49-58.
Crossref
Richard Dodel, Christopher Kruse, Annette Conrads-Frank & Uwe Siebert. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 135 .
Carolina Barbosa, Hannah Fraser, Thomas J. Hoerger, Alyssa Leib, Jennifer R. Havens, April Young, Alex Kral, Kimberly Page, Jennifer Evans, Jon Zibbell, Susan Hariri, Claudia Vellozzi, Lina Nerlander, John W. Ward & Peter Vickerman. (2019) Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs. Addiction 114:12, pages 2267-2278.
Crossref
Barbara Andraka-Christou, Meghan Gabriel, Jody Madeira & Ross D. Silverman. (2019) Court personnel attitudes towards medication-assisted treatment: A state-wide survey. Journal of Substance Abuse Treatment 104, pages 72-82.
Crossref
Iuliia Makarenko, Iryna Pykalo, Sandra A. Springer, Alyona Mazhnaya, Ruthanne Marcus, Sergii Filippovich, Sergii Dvoriak & Frederick L. Altice. (2019) Treating opioid dependence with extended-release naltrexone (XR-NTX) in Ukraine: Feasibility and three-month outcomes. Journal of Substance Abuse Treatment 104, pages 34-41.
Crossref
Aaron D. Fox, Andrea U. Jakubowski & Jonathan Giftos. 2019. Treating Opioid Addiction. Treating Opioid Addiction 197 222 .
Jose Luis Burgos, Javier A. Cepeda, James G. Kahn, Maria Luisa Mittal, Emilio Meza, Raúl Rafael Palacios Lazos, Psyché Calderón Vargas, Peter Vickerman, Steffanie A. Strathdee & Natasha K. Martin. (2018) Cost of provision of opioid substitution therapy provision in Tijuana, Mexico. Harm Reduction Journal 15:1.
Crossref
Lisa Pullen, Amanda Abbott, Ashley Lawhorn & Sarah Harder. (2018) A review of the use of oral and injectable naltrexone for alcohol and opioid addiction treatment. Mental Health Practice 21:10, pages 46-51.
Crossref
Sade E. Johns, Mary Bowman & F. Gerard Moeller. (2018) Future Directions Incorporating Novel Medications to Reduce Repeat Overdose. Current Treatment Options in Psychiatry 5:3, pages 313-322.
Crossref
Christina M. AndrewsColleen M. GroganBikki Tran SmithAmanda J. AbrahamHarold A. PollackKeith HumphreysMelissa A. WestlakePeter D. Friedmann. (2018) Medicaid Benefits For Addiction Treatment Expanded After Implementation Of The Affordable Care Act. Health Affairs 37:8, pages 1216-1222.
Crossref
Hannah Fraser, Jon Zibbell, Thomas Hoerger, Susan Hariri, Claudia Vellozzi, Natasha K. Martin, Alex H. Kral, Matthew Hickman, John W. Ward & Peter Vickerman. (2018) Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction 113:1, pages 173-182.
Crossref
Roger G. Kathol, Rachel L. Andrew, Michelle Squire & Peter J. DehnelRoger G. Kathol, Rachel L. Andrew, Michelle Squire & Peter J. Dehnel. 2018. The Integrated Case Management Manual. The Integrated Case Management Manual 41 52 .
Sean M. Murphy, Daniel Polsky, Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock, Edward V. Nunes, Richard J. Bonnie, Michael Gordon, Donna T. Chen, Tamara Y. Boney & Charles P. O'Brien. (2017) Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder. Addiction 112:8, pages 1440-1450.
Crossref
Paula Becker & Monica Kayo. 2017. Mental Health Economics. Mental Health Economics 323 338 .
Van Phuong Hoang, Marian Shanahan, Nagesh Shukla, Pascal Perez, Michael Farrell & Alison Ritter. (2016) A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problems. BMC Health Services Research 16:1.
Crossref
Sean M. Murphy & Daniel Polsky. (2016) Economic Evaluations of Opioid Use Disorder Interventions. PharmacoEconomics 34:9, pages 863-887.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.